Cardio Diagnostics Holdings, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14,825 | $34,890 | $17,065 | $950 | $901 |
| Research and development | $641,212 | $227,966 | $145,182 | $40,448 | $31,468 |
| Operating expenses | $6.5M | $8.4M | $7.3M | $4.5M | $621,349 |
| Operating income | -$6.5M | -$8.4M | -$7.2M | -$4.5M | -$620,448 |
| Interest expense | $14,801 | $18,640 | $6.7M | — | — |
| Pretax income | -$6.5M | -$8.4M | -$8.4M | -$4.7M | -$620,448 |
| Income tax expense | — | — | — | $0 | $0 |
| Net income | -$6.5M | -$8.4M | -$8.4M | -$4.7M | -$620,448 |
| Balance Sheet | |||||
| Cash and equivalents | $0 | $0 | $0 | $0 | $0 |
| Current assets | $5.9M | $8.8M | $2.8M | $5.9M | $803,507 |
| Total assets | $7.8M | $10.6M | $4.5M | $6.2M | $1.1M |
| Current liabilities | $604,839 | $631,695 | $841,142 | $1.9M | $124,434 |
| Total liabilities | $793,061 | $1.1M | $1.5M | $1.9M | $33,885 |
| Stockholders' equity | $7.0M | $9.6M | $3.0M | $4.3M | $1.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$5.7M | -$5.0M | -$5.7M | -$5.1M | -$585,291 |
| Depreciation and amortization | $160,063 | $113,777 | $3,790 | $0 | $16,000 |
| Stock-based compensation | $110,235 | $2.6M | $1.3M | $0 | $60,000 |
| Capital expenditure | $187,317 | $214,765 | $575,663 | — | — |
| Free cash flow | -$5.9M | -$5.2M | -$6.2M | — | — |
Shares outstanding 3.0M
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.